MX2020001766A - Composiciones de aminoacidos para el tratamiento de lesion neuronal. - Google Patents

Composiciones de aminoacidos para el tratamiento de lesion neuronal.

Info

Publication number
MX2020001766A
MX2020001766A MX2020001766A MX2020001766A MX2020001766A MX 2020001766 A MX2020001766 A MX 2020001766A MX 2020001766 A MX2020001766 A MX 2020001766A MX 2020001766 A MX2020001766 A MX 2020001766A MX 2020001766 A MX2020001766 A MX 2020001766A
Authority
MX
Mexico
Prior art keywords
amino acids
chain amino
branched
treatment
neuronal injury
Prior art date
Application number
MX2020001766A
Other languages
English (en)
Inventor
Sean Carroll
Raffi Afeyan
Rienzo Gianluca De
Matthew Russell
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of MX2020001766A publication Critical patent/MX2020001766A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0626—Isoleucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0628—Leucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0634—N-Acetyl-Cysteine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0654—Valine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/30—Other Organic compounds
    • A23V2250/306—Creatine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Se describen composiciones que comprenden aminoácidos ramificados, N-acetilcisteína y acetil-L-carnitina para usarse en el tratamiento o prevención de lesión neuronal en un sujeto, por ejemplo, un sujeto en riesgo de o que tiene lesión cerebral traumática o accidente cerebrovascular.
MX2020001766A 2017-08-14 2018-08-14 Composiciones de aminoacidos para el tratamiento de lesion neuronal. MX2020001766A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762545364P 2017-08-14 2017-08-14
US201862614198P 2018-01-05 2018-01-05
US201862697690P 2018-07-13 2018-07-13
PCT/US2018/046659 WO2019036442A1 (en) 2017-08-14 2018-08-14 AMINO ACIDS BRANCHED FOR THE TREATMENT OF NEURONAL INJURY

Publications (1)

Publication Number Publication Date
MX2020001766A true MX2020001766A (es) 2020-07-29

Family

ID=63449701

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020001766A MX2020001766A (es) 2017-08-14 2018-08-14 Composiciones de aminoacidos para el tratamiento de lesion neuronal.

Country Status (18)

Country Link
US (1) US20190046486A1 (es)
EP (1) EP3684350A1 (es)
JP (2) JP7370960B2 (es)
KR (1) KR20200040276A (es)
CN (1) CN111295186A (es)
AU (1) AU2018318091A1 (es)
BR (1) BR112020002244A2 (es)
CA (1) CA3072092A1 (es)
CL (1) CL2020000383A1 (es)
CO (1) CO2020001627A2 (es)
IL (1) IL272336A (es)
JO (1) JOP20200035A1 (es)
MA (1) MA50155A (es)
MX (1) MX2020001766A (es)
PE (1) PE20200748A1 (es)
SG (1) SG11202001131TA (es)
TW (1) TW201919602A (es)
WO (1) WO2019036442A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN110678172A (zh) 2017-04-28 2020-01-10 胺细拉健康公司 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo
EP3810168A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Methods of manufacturing amino acid compositions
EP4192441A1 (en) * 2020-08-06 2023-06-14 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Oleylcysteineamide or derivatives thereof and their use in therapy
US20220218640A1 (en) * 2021-01-14 2022-07-14 Rob Dickerman Amino acid delivery system
US11931127B1 (en) * 2021-04-08 2024-03-19 T-Mobile Usa, Inc. Monitoring users biological indicators using a 5G telecommunication network
TW202315605A (zh) 2021-07-26 2023-04-16 美商胺細拉健康公司 用於治療ｃｏｖｉｄ—１９急性後期後遺症的胺基酸組合物及方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438144A (en) * 1980-07-31 1984-03-20 Blackburn George L Amino acid preparation and therapy for treatment of stress and injury
US20050107338A1 (en) * 2003-11-17 2005-05-19 Seidman Michael D. Nutritional supplement enhancing mitochondrial function
JP5290744B2 (ja) * 2005-03-21 2013-09-18 アボット・ラボラトリーズ 糖耐性を改善するためのアミノ酸組成物
CN101693740B (zh) * 2009-10-16 2011-09-07 中国人民解放军第四军医大学 Homer1蛋白及其在治疗或预防脑损伤疾病中的应用
JP6099574B2 (ja) * 2011-02-04 2017-03-22 ハフ イヤ インスティテュート 外傷性脳損傷を処置する方法
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US20130090356A1 (en) * 2011-06-24 2013-04-11 Jon D. Kaiser Compositions and methods for treatment of neuropsychological deficits
CA2799127C (en) * 2012-12-18 2021-05-18 Matthew Bennett Compositions and methods for treating traumatic brain injury
US20160058726A1 (en) * 2013-04-16 2016-03-03 The Children's Hospital Of Philadelphia Compositions and methods for the treatment of brain injury
CN106361738A (zh) * 2016-08-25 2017-02-01 南通大学 治疗、预防脑白质损伤的医药组合物及其医药用途
US20180133185A1 (en) * 2016-11-11 2018-05-17 The Children's Hospital Of Philadelphia Compositions and Methods for the Improvement of Memory
JOP20190147A1 (ar) * 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
JOP20190146A1 (ar) * 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد

Also Published As

Publication number Publication date
SG11202001131TA (en) 2020-03-30
BR112020002244A2 (pt) 2020-08-04
JOP20200035A1 (ar) 2020-02-13
US20190046486A1 (en) 2019-02-14
IL272336A (en) 2020-03-31
AU2018318091A1 (en) 2020-02-13
JP2020530843A (ja) 2020-10-29
JP7370960B2 (ja) 2023-10-30
CA3072092A1 (en) 2019-02-21
EP3684350A1 (en) 2020-07-29
JP2023145496A (ja) 2023-10-11
CL2020000383A1 (es) 2020-08-28
WO2019036442A9 (en) 2020-02-13
TW201919602A (zh) 2019-06-01
CN111295186A (zh) 2020-06-16
AU2018318091A8 (en) 2020-03-12
WO2019036442A1 (en) 2019-02-21
PE20200748A1 (es) 2020-07-24
CO2020001627A2 (es) 2020-06-09
KR20200040276A (ko) 2020-04-17
MA50155A (fr) 2020-07-29

Similar Documents

Publication Publication Date Title
MX2020001766A (es) Composiciones de aminoacidos para el tratamiento de lesion neuronal.
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
IL276217A (en) Use of cannabinoids in the treatment of epilepsy
WO2016113357A8 (en) Proteasome inhibitors for treating a disorder related to an accumulation of non-degraded abnormal protein or a cancer
WO2016070051A3 (en) Combination therapy for treatment of disease
IL283372A (en) Use of cannabinoids to treat epilepsy
IL268327A (en) A pharmaceutical preparation for use in the treatment and prevention of c5-related diseases and methods for the treatment and prevention of c5-related diseases
IL285662A (en) Use of cannabinoids to treat epilepsy
WO2017106364A3 (en) Compositions and methods for treatment of retinitis pigmentosa 18 and retinitis pigmentosa 13
BR112017009584A2 (pt) tratamento de retinite pigmentosa com n-acetilcisteína amida
SG11201912103TA (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
WO2017040666A3 (en) Combination therapy for treatment of disease
IL283654A (en) Decarboxylase inhibitors for the treatment of Parkinson's disease
PL3250186T3 (pl) Kompozycje zawierające a) chitozan, b) kwas glikolowy, c) karnitynę i/lub n-acetylocysteinę do zabiegu peelingu skórno-naskórkowego
WO2016134257A8 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
AR106313A1 (es) Combinación de levodopa deuterada con carbidopa y opicapona para el tratamiento de enfermedad de parkinson
WO2016135456A3 (en) A gm-csf negative modulator for use in treating, preventing or ameliorating aortopathy
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
SG11201912098SA (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases
EP3881845A3 (en) Combination of trazodone and gabapentin for the treatment of pain
EA202090460A1 (ru) Композиции и способы для лечения нейронального повреждения
EP3829564C0 (en) CURCUMIN AND HOMOTAURINE FOR USE IN THE PREVENTION OR TREATMENT OF FORMS OF COGNITIVE DECLINE
GB201915519D0 (en) Use of cannabidiol preparations in the treatment of temporal lobe epilepsy
MX2021005972A (es) Butirato alimenticio para tratar o prevenir un trastorno alergico.
GB201907204D0 (en) Cancer treatment 3